Hugo Muench
Tufts University
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Hugo Muench.
Annals of Internal Medicine | 1969
Donald O. Castell; Kevin D. O'brien; Hugo Muench; Thomas C. Chalmers
Abstract Estimation of liver size by percussion was determined in 116 normal subjects by three examiners. Factors responsible for variation in percussion measurement within and between examiners we...
The New England Journal of Medicine | 1964
Arthur J. Garceau; Robert M. Donaldson; Edward T. O'Hara; Allan D. Callow; Hugo Muench; Thomas C. Chalmers
PATIENTS with cirrhosis and varices often die after esophageal hemorrhage. In a retrospective analysis of the records of 106 patients appearing in the years 1918–1938 only 30 per cent survived for ...
The New England Journal of Medicine | 1966
Hershel Jick; Dennis Slone; Barbara J. Dinan; Hugo Muench
INCREASED awareness of the importance of properly controlled drug evaluations has brought with it a need for the development of experimental technics that can provide essential information about dr...
The American Journal of Medicine | 1963
Melvin J. Krant; Thomas C. Chalmers; Margarida M. Dederick; Thomas C. Hall; Martin B. Levene; Hugo Muench; Bruce I. Shnider; G. Lennard Gold; Charles Hunter; Solomon R. Bersack; Albert H. Owens; Natividad de Leon; Robert J. Dickson; Clyde O. Brindley; Kirkland C. Brace; Emil Frei; Edmund A. Gehan; Leonard Salvin
Abstract Two hundred and nineteen patients with carcinoma of the lung were studied in three treatment groups in a cooperative in-hospital study. Of these patients, 196 had not received prior therapy. Treatment group I was given a mean of 3,843 tissue r., treatment group II a mean of 37.8 mg. of nitrogen mustard therapy and 3,658 tissue r. simultaneously and treatment group III 41.0 mg. nitrogen mustard therapy followed by 3,633 tissue r. In evaluating shrinkage in tumor size, benefits as determined by votes of the investigators and over-all survival curves, essentially no beneficial differences emerged for any one treatment group. Toxicity was slightly greater in group II, and treatment time extended for these same patients. No difference in toxicity or survival time appeared between 250 kv. or 2 Mev radiotherapy equipment. Data and discussion are presented to indicate that in this study survival time is independent of the form of treatment administered but that natural selection alone determines the patients with longer survivorship. The routine use of radiotherapy and mechlorethamine treatment, therefore, is questioned.
The New England Journal of Medicine | 1962
Rafael A. Camerini-Davalos; Alexander Marble; Hugo Muench
MANY reports have been published regarding the outcome of liver-function tests both in healthy persons and in those with pathologic states. The data have shown considerable variation from one study...
Gastroenterology | 1966
Norman D. Grace; Hugo Muench; Thomas C. Chalmers
The Lancet | 1966
Dennis Slone; Hershel Jick; Ivan Borda; ThomasC. Chalmers; Manning Feinleib; Hugo Muench; Leslie Lipworth; Carole Bellotti; Barry Gilman
The New England Journal of Medicine | 1963
Frederick Beerel; Hershel Jick; John M. Tyler; SusanMiss Gordon; Hugo Muench
American Journal of Surgery | 1969
Hans B. Nevinny; Dagmar Nevinny; Chester B. Rosoff; Thomas C. Hall; Hugo Muench
Archive | 1966
Dennis Slone; Hershel Jick; Ivan Borda; ThomasC. Chalmers; Manning Feinleib; Hugo Muench; Leslie Lipworth; Carole Bellotti; Barry Gilman